Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly

Haematologica. 2003 Dec;88(12):ECR37.

Authors

Pier Paolo Piccaluga¹, Giovanni Martinelli, Michela Rondoni, Michele Malagola, Sonia Ronconi, Giuseppe Visani, Michele Baccarani

Affiliation

¹ Institute of Haematology and Medical Oncology L. and A. Seràgnoli, S. Orsola-Malpighi Hospital, University of Bologna, Italy.

PMID: 14688010

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Aminoglycosides / administration & dosage
Aminoglycosides / therapeutic use*
Antibodies, Monoclonal / administration & dosage
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bone Marrow Transplantation
Cytarabine / administration & dosage
Etoposide / administration & dosage
Gemtuzumab
Humans
Idarubicin / administration & dosage
Immunotoxins / administration & dosage
Immunotoxins / therapeutic use*
Leukemia, Myeloid, Acute / drug therapy*
Leukemia, Myeloid, Acute / therapy
Male
Middle Aged
Recurrence
Salvage Therapy
Transplantation, Autologous

Substances

Aminoglycosides
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Immunotoxins
Cytarabine
Etoposide
Gemtuzumab
Idarubicin